COMBI.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

DCF fair valuemodel estimate

Intrinsic value

$3.71

Price

$2.47

Implied upside

+50%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
COMBI.STCombiGene AB (publ)	$2.47	-3.89%	$49M	—
AMNI.STAmniotics AB (publ)	$0.01	+5.88%	$15M	—
CLINE-B.STCline Scientific AB (publ)	$0.07	+0.00%	$3M	—
DIABIO.STDiagonal Bio AB (publ)	$0.01	+0.00%	$20M	—
EMPLI.STEmplicure AB (publ)	$0.47	+0.86%	$46M	—
FRISQ.STFRISQ Holding AB (publ)	$0.70	+6.38%	$47M	—
IDOGEN.STIdogen AB (publ)	$0.12	-2.82%	$13M	—

Source: Financial Modeling Prep · peers by sector/industry

CombiGene AB (publ)

Headquartered in Lidingö, Sweden, CombiGene AB (publ) was established in 1999 and specializes in pioneering gene therapy solutions for severe, life-altering medical conditions. The company is currently advancing two primary gene therapy candidates in its pipeline. CG01, a treatment targeting epilepsy, is undergoing preclinical trials that include detailed biodistribution and toxicology assessments. Its second candidate, CGT2, is under development for addressing lipodystrophy. CombiGene also maintains strategic alliances, including a licensing and collaborative agreement with Lipigon Pharmaceuticals AB to create a gene therapy for partial lipodystrophy, and a partnership with Spark Therapeutics for the advancement of adeno-associated virus (AAV) based gene therapies.

www.combigene.com

Employees: 9
IPO / List date: May 25, 2015
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds COMBI.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in COMBI.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded COMBI.ST yet.